Menopausal symptoms in women with chronic kidney disease

Menopause

Volumn 22, Issue 9, 2015, Pages 1006-1011

  Cheung, Katharine L ^a   Stefanick, Marcia L ^b,c   Allison, Matthew A ^d   Leblanc, Erin S ^e   Vitolins, Mara Z ^f   Shara, Nawar ^g   Chertow, Glenn M ^b   Winkelmayer, Wolfgang C ^h   Tamura, Manjula Kurella ^b,i  

^a UNIVERSITY OF VERMONT   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CENTER FOR HEALTH RESEARCH   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g GEORGETOWN UNIVERSITY   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Cardiovascular; Epidemiology; Kidney disease; Menopause; Vasomotor symptoms

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MORTALITY; NIGHT SWEAT; POSTMENOPAUSE; VASOMOTOR DISORDER; MIDDLE AGED; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES; WOMEN'S HEALTH;

AGED; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MENOPAUSE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES; WOMEN'S HEALTH;

EID: 84956717022     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000416     Document Type: Article

References (39)

1. National Institutes of Health. National Institutes of Health State-of-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005; 142(pt 1): 1003-1013
2. Deecher DC, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Mental Health 2007; 10: 247-257
3. Gerber LM, Sievert LL, Warren K, Pickering TG, Schwartz JE. Hot flashes are associated with increased ambulatory systolic blood pressure. Menopause 2007; 14: 308-315
4. Lambrinoudaki I, Augoulea A, Armeni E, et al. Menopausal symptoms are associated with subclinical atherosclerosis in healthy recently postmenopausal women. Climacteric 2012; 15: 350-357
5. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation 2008; 118: 1234-1240
6. GastGC, GrobbeeDE, Pop VJ, et al.Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008; 51: 1492-1498
7. Allison MA, Manson JE, Aragaki A, et al. Vasomotor symptoms and coronary artery calcium in postmenopausal women. Menopause 2010; 17: 1136-1145
8. Szmuilowicz ED, Manson JE, Rossouw JE, et al. Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause 2011; 18: 603-610
9. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
10. Shoji T, Emoto M, Tabata T, et al. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int 2002; 61: 2187-2192
11. Nickolas TL, Leonard MB, Shane E. Chronic kidney disease and bone fracture: a growing concern. Kidney Int 2008; 74: 721-731
12. Lim VS. Reproductive function in patients with renal insufficiency. Am J Kidney Dis 1987; 9: 363-367
13. Alem AM, Sherrard DJ, Gillen DL, et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 2000; 58: 396-399
14. Kawagishi T, Nishizawa Y, Konishi T, et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 1995; 48: 820-826
15. Nickolas TL, McMahon DJ, Shane E. Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 2006; 17: 3223-3232
16. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
17. Anderson GL, Manson J, Wallace R, et al. Implementation of the Women's Health Initiative study design. Ann Epidemiol 2003; 13(suppl 9): S5-S17
18. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998; 19: 61-109
19. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
20. Curb JD, McTiernan A, Heckbert SR, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003; 13(suppl 9): S122-S128
21. Rathi M, Ramachandran R. Sexual and gonadal dysfunction in chronic kidney disease: pathophysiology. Indian J Endocrinol Metab 2012; 16: 214-219
22. Holley JL, Schmidt RJ, Bender FH, Dumler F, Schiff M. Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis 1997; 29: 685-690
23. Shanmugavadivoo K, Shaariah W. Health issues in dialysis-dependent female patients. Perit Dial Int 2003; 23(suppl 2): S192-S195
24. Lai CF, Tsai HB, Hsu SH, Chiang CK, Huang JW, Huang SJ. Withdrawal from long-Term hemodialysis in patients with end-stage renal disease in Taiwan. J Formos Med Assoc 2013; 112: 589-599
25. Lim VS, Henriquez C, Sievertsen G, Frohman LA. Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation. Ann Intern Med 1980; 93: 21-27
26. Ghazizadeh S, Lessan-Pezeshki M, Mahdavi M, Razeghi E, Seifi S. Menstrual problems among kidney transplant recipients. Transplant Proc 2003; 35: 2720-2721
27. Kim JH, Chun CJ, Kang CM, Kwak JY. Kidney transplantation and menstrual changes. Transplant Proc 1998; 30: 3057-3059
28. Stenvinkel P, Larsson TE. Chronic kidney disease: a clinical model of premature aging. Am J Kidney Dis 2013; 62: 339-351
29. Finkelstein FO, Shirani S, Wuerth D, Finkelstein SH. Therapy insight: sexual dysfunction in patients with chronic kidney disease. Nat Clin Pract Nephrol 2007; 3: 200-207
30. Anantharaman P, Schmidt RJ. Sexual function in chronic kidney disease. Adv Chronic Kidney Dis 2007; 14: 119-125
31. Weisinger JR, Bellorin-Font E. Outcomes associated with hypogonadism in women with chronic kidney disease. Adv Chronic Kidney Dis 2004; 11: 361-370
32. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147-152
33. Disthabanchong S. Vascular calcification in chronic kidney disease: pathogenesis and clinical implication. World J Nephrol 2012; 1: 43-53
34. DuPont JJ, Ramick MG, Farquhar WB, Townsend RR, Edwards DG. NADPH oxidase-derived reactive oxygen species contribute to impaired cutaneous microvascular function in chronic kidney disease. Am J Physiol Renal Physiol 2014; 306: F1499-F1506
35. Churchill DN, Jassal SV. Dialysis: destination or journey. J Am Soc Nephrol 2014; 25: 1609-1611
36. Meyer TW, Hostetter TH. Uremia. N Engl J Med 2007; 357: 1316-1325
37. Palmer BF. Sexual dysfunction in uremia. J Am Soc Nephrol 1999; 10: 1381-1388
38. Crawford SL, Avis NE, Gold E, et al. Sensitivity and specificity of recalled vasomotor symptoms in a multiethnic cohort. Am J Epidemiol 2008; 168: 1452-1459
39. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297: 1465-1477